Unlock stock picks and a broker-level newsfeed that powers Wall Street.

TSXV - Free Realtime Quote CAD

Kane Biotech Inc. (KNE.V)

Compare
0.1000
0.0000
(0.00%)
As of 10:12:07 AM EDT. Market Open.

Valuation Measures

Annual Monthly
Currency in CAD Download
Current9/30/20246/30/20243/31/202412/31/20239/30/2023
Market Cap 15.03M 18.55M 19.88M 13.18M 10.55M 9.86M
Enterprise Value 16.76M 19.93M 28.25M 21.69M 18.12M 16.80M
Trailing P/E 1.79 -- -- -- -- --
Forward P/E -- -- -- -- -- --
PEG Ratio (5yr expected) -- -- -- -- -- --
Price/Sales 6.58 24.59 116.74 85.33 -- 3.62
Price/Book 104.38 -- -- -- -- --
Enterprise Value/Revenue 8.33 26.32 170.58 145.57 6.60 6.46
Enterprise Value/EBITDA -6.17 -- -- -- -30.73 -15.21
9/30/2023 - 10/1/2003

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2023
Most Recent Quarter (mrq) 9/30/2024

Profitability

Profit Margin 278.16%
Operating Margin (ttm) -47.66%

Management Effectiveness

Return on Assets (ttm) -52.36%
Return on Equity (ttm) --

Income Statement

Revenue (ttm) 2.01M
Revenue Per Share (ttm) 0.01
Quarterly Revenue Growth (yoy) 4,650.20%
Gross Profit (ttm) 993.6k
EBITDA -4.15M
Net Income Avi to Common (ttm) -4.91M
Diluted EPS (ttm) 0.0600
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 544.38k
Total Cash Per Share (mrq) 0
Total Debt (mrq) 2.29M
Total Debt/Equity (mrq) --
Current Ratio (mrq) 0.80
Book Value Per Share (mrq) -0.00

Cash Flow Statement

Operating Cash Flow (ttm) -5.62M
Levered Free Cash Flow (ttm) -2.32M

Trading Information

Stock Price History

Beta (5Y Monthly) 0.25
52 Week Change 3 -23.08%
S&P 500 52-Week Change 3 2.82%
52 Week High 3 0.1700
52 Week Low 3 0.0900
50-Day Moving Average 3 0.1030
200-Day Moving Average 3 0.1221

Share Statistics

Avg Vol (3 month) 3 52.61k
Avg Vol (10 day) 3 31.01k
Shares Outstanding 5 150.26M
Implied Shares Outstanding 6 150.26M
Float 8 89.47M
% Held by Insiders 1 33.63%
% Held by Institutions 1 0.00%
Shares Short (3/17/2025) 4 4
Short Ratio (3/17/2025) 4 0
Short % of Float (3/17/2025) 4 --
Short % of Shares Outstanding (3/17/2025) 4 0.00%
Shares Short (prior month 2/18/2025) 4 15.54k

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 3/13/2017
Ex-Dividend Date 4 --
Last Split Factor 2 1:5
Last Split Date 3 3/13/2017

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq = Most Recent Quarter
  • ttm = Trailing Twelve Months
  • yoy = Year Over Year
  • lfy = Last Fiscal Year
  • fye = Fiscal Year Ending

Related Tickers